Kim JW - Search Results

1

Methylation of RUNX3 in various types of human cancers and premalignant stages of gastric carcinoma.

Kim TY, Lee HJ, Hwang KS, Lee M, Kim JW, Bang YJ, Kang GH. Kim TY, et al. Among authors: kim jw. Lab Invest. 2004 Apr;84(4):479-84. doi: 10.1038/labinvest.3700060. Lab Invest. 2004. PMID: 14968123 Free article.

2

Hypermethylation of the COX-2 gene is a potential prognostic marker for cervical cancer.

Jo H, Kang S, Kim JW, Kang GH, Park NH, Song YS, Park SY, Kang SB, Lee HP. Jo H, et al. Among authors: kim jw. J Obstet Gynaecol Res. 2007 Jun;33(3):236-41. doi: 10.1111/j.1447-0756.2007.00517.x. J Obstet Gynaecol Res. 2007. PMID: 17578348

3

Pyrophosphatase overexpression is associated with cell migration, invasion, and poor prognosis in gastric cancer.

Jeong SH, Ko GH, Cho YH, Lee YJ, Cho BI, Ha WS, Choi SK, Kim JW, Lee CW, Heo YS, Shin SH, Yoo J, Hong SC. Jeong SH, et al. Among authors: kim jw. Tumour Biol. 2012 Dec;33(6):1889-98. doi: 10.1007/s13277-012-0449-5. Epub 2012 Jul 14. Tumour Biol. 2012. PMID: 22797819

4

Comparative analysis of nuclear proteins of B cells in different developmental stages.

Jin SH, Cho EH, Ko JE, Jung EH, Ahn B, Hahm JR, Kim JW, Kim CW, Kim DR. Jin SH, et al. Among authors: kim cw, kim jw, kim dr. Proteomics. 2003 Dec;3(12):2428-36. doi: 10.1002/pmic.200300576. Proteomics. 2003. PMID: 14673793

5

RhoGDI2 expression is associated with tumor growth and malignant progression of gastric cancer.

Cho HJ, Baek KE, Park SM, Kim IK, Choi YL, Cho HJ, Nam IK, Hwang EM, Park JY, Han JY, Kang SS, Kim DC, Lee WS, Lee MN, Oh GT, Kim JW, Lee CW, Yoo J. Cho HJ, et al. Among authors: kim dc, kim ik, kim jw. Clin Cancer Res. 2009 Apr 15;15(8):2612-9. doi: 10.1158/1078-0432.CCR-08-2192. Epub 2009 Apr 7. Clin Cancer Res. 2009. PMID: 19351766

6

Overexpression of nicotinamide N-methyltransferase in gastric cancer tissues and its potential post-translational modification.

Lim BH, Cho BI, Kim YN, Kim JW, Park ST, Lee CW. Lim BH, et al. Among authors: kim yn, kim jw. Exp Mol Med. 2006 Oct 31;38(5):455-65. doi: 10.1038/emm.2006.54. Exp Mol Med. 2006. PMID: 17079861

7

RhoGDI2 confers gastric cancer cells resistance against cisplatin-induced apoptosis by upregulation of Bcl-2 expression.

Cho HJ, Baek KE, Park SM, Kim IK, Nam IK, Choi YL, Park SH, Im MJ, Choi J, Ryu J, Kim JW, Lee CW, Kang SS, Yoo J. Cho HJ, et al. Among authors: kim ik, kim jw. Cancer Lett. 2011 Dec 1;311(1):48-56. doi: 10.1016/j.canlet.2011.06.024. Epub 2011 Jun 24. Cancer Lett. 2011. PMID: 21752536

8

Prognostic value of CAPZA1 overexpression in gastric cancer.

Lee YJ, Jeong SH, Hong SC, Cho BI, Ha WS, Park ST, Choi SK, Jung EJ, Ju YT, Jeong CY, Kim JW, Lee CW, Yoo J, Ko GH. Lee YJ, et al. Among authors: kim jw. Int J Oncol. 2013 May;42(5):1569-77. doi: 10.3892/ijo.2013.1867. Epub 2013 Mar 27. Int J Oncol. 2013. PMID: 23545944 Free PMC article.

9

RhoGDI2 promotes epithelial-mesenchymal transition via induction of Snail in gastric cancer cells.

Cho HJ, Park SM, Kim IK, Nam IK, Baek KE, Im MJ, Yoo JM, Park SH, Ryu KJ, Han HT, Kim HJ, Hong SC, Kim KD, Pak Y, Kim JW, Lee CW, Yoo J. Cho HJ, et al. Among authors: kim ik, kim hj, kim kd, kim jw. Oncotarget. 2014 Mar 30;5(6):1554-64. doi: 10.18632/oncotarget.1733. Oncotarget. 2014. PMID: 24721928 Free PMC article.

10

Proteomics-based strategy to delineate the molecular mechanisms of RhoGDI2-induced metastasis and drug resistance in gastric cancer.

Cho HJ, Baek KE, Kim IK, Park SM, Choi YL, Nam IK, Park SH, Im MJ, Yoo JM, Ryu KJ, Oh YT, Hong SC, Kwon OH, Kim JW, Lee CW, Yoo J. Cho HJ, et al. Among authors: kim ik, kim jw. J Proteome Res. 2012 Apr 6;11(4):2355-64. doi: 10.1021/pr2011186. Epub 2012 Mar 12. J Proteome Res. 2012. PMID: 22364609

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8,735 results

Search Page